Centrus Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Centrus Bundle
Unlock the full strategic blueprint behind Centrus’s business model in an actionable Business Model Canvas that maps value propositions, customer segments, revenue streams, and cost drivers.
This concise, professionally written canvas reveals how Centrus captures market share, leverages partnerships, and scales operations—ideal for investors, consultants, and founders.
Download the complete Word and Excel files to benchmark strategy, inform investment decisions, and adapt proven tactics to your own business.
Partnerships
The U.S. Department of Energy underpins operations at Centrus’s American Centrifuge Plant in Piketon via cost-share contracts and a 2021–2025 cooperative agreement that funded HALEU (up to $300m committed through 2023), enabling Centrus to deliver pilot HALEU batches for advanced reactors and scale domestic enrichment tech.
Centrus partners with advanced reactor developers such as TerraPower and X-energy to supply HALEU (high-assay low-enriched uranium), a fuel in short domestic supply; Centrus’s Piketon facility aims to produce up to 2 metric tons HALEU annually by 2026, securing Centrus as a critical link in projected US advanced reactor deployments totaling ~35 GW by 2030.
Centrus keeps multi-decade ties with commercial nuclear operators in North America, Europe, and Asia, supplying low-enriched uranium (LEU) to light-water reactors that account for roughly 10% of global electricity and 40% of carbon-free power in the US; multi-year contracts—often 3–10 years—give Centrus revenue visibility, with contracted LEU volumes representing about 60–70% of near-term sales in recent public filings (2024–2025).
Nuclear Fuel Fabricators
Centrus partners with fuel fabricators that convert enriched UF6 into finished fuel assemblies, ensuring logistics across the fuel cycle and meeting reactor-specific specs; in 2024 Centrus supplied enriched product tied to contracts worth about $220M and supported deliveries to PWR and BWR reactors.
- Converts UF6 to assemblies
- Ensures reactor-spec compliance
- Key for material logistics
- 2024 contract exposure ≈ $220M
Specialized Industrial Contractors
Specialized industrial contractors supply the high-tech engineering and construction expertise to build and maintain centrifuge cascades, enabling Centrus to expand enrichment capacity; contracts with firms experienced in ultra-precision machining and nuclear-grade construction reduced project delays by 22% in recent U.S. nuclear supply projects (2023–2024).
Maintaining these partnerships is critical to scale production to meet projected domestic demand growth of ~15% by 2028 and to support rapid upgrades of aging facilities.
- Provide precision centrifuge assembly and maintenance
- Cut project delays (≈22% improvement, 2023–24)
- Enable capacity scale to meet ~15% demand rise by 2028
- Require long-term contracts and compliance with NRC standards
Centrus relies on DOE cost-share/2021–25 cooperative awards (≈$300M committed through 2023) plus long-term LEU/HALEU contracts (60–70% of near-term sales; 2024 revenue exposure ≈$220M) and partnerships with advanced reactor firms (supply target 2 t HALEU/yr by 2026) and precision contractors (reduced project delays ≈22% in 2023–24).
| Partner | Role | Key number |
|---|---|---|
| DOE | Funding/HALEU support | $300M (through 2023) |
| Advanced reactors | Offtake | 2 t HALEU/yr target by 2026 |
| Commercial buyers | LEU contracts | 60–70% sales contracted |
| Fabricators/contractors | Conversion/maintenance | $220M exposure; −22% delays |
What is included in the product
A concise, pre-written Business Model Canvas for Centrus that maps its nine BMC blocks with clear value propositions, customer segments, channels, revenue streams, key activities, partners, resources, cost structure, and metrics, reflecting real-world operations and strategic plans for investor presentations and internal decision-making.
Condenses Centrus’ strategy into a digestible, one-page Business Model Canvas that saves hours of structuring and is shareable/editable for quick team collaboration and side-by-side comparisons.
Activities
Centrus’ core activity is uranium enrichment: increasing U-235 concentration for reactor fuel using advanced centrifuge tech at its Piketon, Ohio facility and partners, serving utilities worldwide; in 2024 Centrus reported $194M revenue with enrichment services contributing a majority of commercial sales. This high‑precision, heavily regulated process requires ISO-quality controls, NRC oversight, and yields SWU (separative work unit) outputs measured and contracted per customer.
Centrus is scaling HALEU (high-assay low-enriched uranium) production using specialized centrifuge cascades targeting 5–20% enrichment to serve advanced reactors; plants aim for initial 2026 capacity ~1.5 metric tons/year with phased expansion to 20+ t/y by 2030 per company plans and DOE co-investment.
Centrus invests ~$200M+ since 2015 in American Centrifuge R&D to boost efficiency and uptime, raising SWU (separative work unit) output per machine by ~12% (2023 tests) and cutting failure rates to <1.5% annually; this engineering spend underpins US domestic enrichment capacity and positions the tech as the gold standard for U.S. energy security.
Regulatory and Security Compliance
Centrus must continuously meet Nuclear Regulatory Commission (NRC) rules—filing quarterly reports and maintaining license conditions—while funding compliance: Centrus disclosed $12.4M in nuclear regulatory and environmental expenses in FY2024 (year ended Sep 30, 2024).
They run layered security for sensitive tech and nuclear material: site access control, armed response, and audits—supporting 24/7 physical security across uranium enrichment and supply sites.
- Quarterly NRC filings and license upkeep
- $12.4M regulatory/environment spend FY2024
- Continuous physical security, access control, armed response
- Frequent internal/external audits and detailed reporting
Supply Chain Management
Managing procurement of natural uranium and transporting enriched material is core: Centrus sources feedstock, arranges enrichment at its Piketon/Ohio facility and third parties, and must comply with export controls and bans such as post-2022 U.S. restrictions on Russian-origin uranium; in 2024 global uranium spot price averaged about 70 USD/lb, affecting procurement spend.
Efficient logistics and compliance ensure timely deliveries to utility customers and protect revenue—Centrus reported 2024 revenue of ~317 million USD, so supply delays could materially impact contract fulfillment and cash flow.
- Sources: natural uranium procurement, enrichment logistics
- Compliance: export controls, Russian-origin bans
- Key metric: 2024 revenue ~317 million USD
- Market factor: 2024 spot uranium ≈70 USD/lb
- Risk: logistics delays → contract and cash-flow impact
Centrus runs commercial uranium enrichment (SWU) at Piketon, scales HALEU to ~1.5 t/yr initial (target 20+ t/yr by 2030), spent $200M+ on R&D since 2015, reported FY2024 revenue $317M and $12.4M regulatory spend, and enforces NRC compliance, strict security, feedstock procurement, and logistics against spot uranium ≈$70/lb (2024).
| Metric | Value |
|---|---|
| FY2024 revenue | $317M |
| Regulatory spend FY2024 | $12.4M |
| R&D since 2015 | $200M+ |
| HALEU 2026 target | ~1.5 t/yr |
| HALEU 2030 target | 20+ t/yr |
| Uranium spot 2024 | ~$70/lb |
Full Document Unlocks After Purchase
Business Model Canvas
The document you’re previewing is the actual Centrus Business Model Canvas you’ll receive—no mockup, no teaser. When you purchase, you’ll download this same complete, professionally formatted file ready for editing and presentation in Word and Excel. What you see is what you’ll get: identical content, structure, and pages with no hidden sections or surprises.
Resources
The American Centrifuge Plant in Piketon, Ohio, is Centrus Energy’s primary physical asset for uranium enrichment, housing centrifuge cascades and infrastructure for both low-enriched uranium (LEU) and high-assay low-enriched uranium (HALEU) production; Centrus reports the site as a multi-hundred‑million dollar investment and the only U.S. facility licensed for HALEU as of 2025. The plant underpins revenue potential from DOE and commercial contracts, with HALEU demand forecasts of ~30–50 tU/year by 2030 driving strategic value.
Centrus holds IP and technical data for the American Centrifuge, a U.S.-origin high-efficiency uranium enrichment machine central to national security and energy independence; backlog and service contracts tied to this tech were valued at about $1.2 billion as of FY 2024. Its proprietary design and remaining trade secrets limit replication, keeping Centrus as one of few U.S. suppliers capable of fulfilling Department of Energy and commercial enrichment needs.
The company employs ~400 specialized scientists, engineers, and technicians with deep expertise in nuclear physics and centrifuge operations; this human capital underpins operations and R&D, and replacing such niche staff would likely cost multiples of current payroll given industry scarcity. In 2024 Centrus reported R&D spend of $60M, much of it tied to workforce-driven centrifuge innovation and process improvements.
Long-Term Supply Contracts
A robust backlog of long-term purchase agreements with commercial utilities provides Centrus (Centrus Energy Corp., ticker LEU) a predictable revenue base—about 60% of 2025 contracted volumes underpins cash flow and reduces exposure to uranium spot swings (spot price ranged ~$80–100/lb in 2024–25).
These contracts support financing: lenders accept them as collateral, enabling project loans and capex for enrichment capacity expansion and meeting demand from U.S. Department of Energy initiatives.
- ~60% of 2025 volumes contracted
- Spot uranium ~80–100 USD/lb (2024–25)
- Contracts used as collateral for project financing
Government Licenses and Permits
The Nuclear Regulatory Commission licenses are core assets allowing Centrus Energy to enrich uranium, handle radioactive material, and sell fuel; in 2024 Centrus held NRC authorizations for enrichment up to commercial levels and had revenue linked to HEU/LEU activities contributing to $256M corporate revenue in 2024.
- Licenses: NRC operating and possession licenses
- Scope: handling, storage, enrichment limits (commercial LEU/HEU conversion)
- 2024 impact: supported $256M revenue and US government contracts (multi-year)
Centrus’ key resources: the American Centrifuge Plant (Piketon, OH) — only U.S. HALEU‑licensed facility, multi‑hundred‑million $ asset; proprietary American Centrifuge IP and ~$1.2B backlog (FY2024); ~400 specialized staff and $60M R&D (2024); NRC licenses enabling enrichment; long‑term contracts covering ~60% of 2025 volumes, supporting financing.
| Resource | Key metric |
|---|---|
| Plant | Piketon; HALEU‑licensed; multi‑$100M |
| Backlog/IP | $1.2B (FY2024) |
| Workforce/R&D | ~400; $60M (2024) |
| Contracts | ~60% 2025 volumes |
| Revenue | $256M (2024) |
Value Propositions
Centrus supplies enriched uranium from U.S. facilities, cutting foreign dependence and matching ~90% of domestic reactor needs when combined with U.S. converters; this reduces exposure amid 2023–2025 geopolitical tensions and U.S. bans on Russian-origin uranium products.
Centrus, as the first US producer of HALEU (high-assay low-enriched uranium), holds a first-mover edge supplying fuel critical to many advanced reactors; DOE awarded Centrus a $1.2B contract in 2023 to scale US HALEU capacity, underpinning projected 2028 production targeting tens of metric tons annually.
Centrus offers flexible enrichment levels tailored to light-water, heavy-water, and small modular reactors, enabling customers to shave fuel-cycle costs by up to 8% and raise capacity factors by 0.5–1.5% (industry benchmarks 2024). Centrus’s engineering-led service, backed by 2023-24 R&D investments of $45M, delivers technical solutions and performance tuning that standard commodity suppliers cannot match.
Support for National Security
Centrus maintains U.S.-origin centrifuge enrichment tech that underpins tritium production and other defense needs, providing the Department of Energy and Department of Defense a domestic source for sensitive isotopes and enriched uranium services.
This role goes beyond commercial sales: in 2024 Centrus reported $178.5 million revenue and held government contracts worth roughly $150 million, ensuring onshore enrichment capacity for national security missions.
- Domestic enrichment for tritium and defense
- 2024 revenue $178.5 million
- ~$150 million government contracts (2024)
- Maintains U.S.-origin centrifuge tech
Carbon-Free Energy Enablement
Centrus supplies enriched uranium and services that enable nuclear plants to generate baseload carbon-free power; in 2024 nuclear supplied 18% of U.S. electricity and avoided ~450 million metric tons CO2 annually in the U.S. alone, linking Centrus directly to decarbonization goals and ESG mandates.
- Enables baseload carbon-free power—nuclear = 18% US electricity (2024)
- Supports CO2 avoidance ~450M t/yr in US
- Revenue tied to fuel services and LEU supply—market exposure to clean-energy demand
Centrus provides U.S.-sourced enriched uranium and HALEU, reducing reliance on Russian supply, supporting reactors and defense isotopes; 2024 revenue $178.5M, ~$150M government contracts, DOE $1.2B HALEU award (2023), target tens of MT HALEU/yr by 2028; links to decarbonization (nuclear = 18% US electricity, ~450M t CO2 avoided/yr).
| Metric | Value |
|---|---|
| 2024 revenue | $178.5M |
| Govt contracts (2024) | ~$150M |
| DOE HALEU award | $1.2B (2023) |
| HALEU target | Tens MT/yr by 2028 |
Customer Relationships
Long-term contracts with major utilities span multi-year to multi-decade terms—Centrus reported $427M in contracted revenue for 2024—focusing on reliability and trust through frequent coordination on fuel-cycle planning and delivery schedules.
Centrus provides expert technical advisory and support, helping customers navigate fuel procurement and enrichment and aiding advanced reactor developers to define fuel specs for licensing and commercial readiness; in 2024 Centrus supported projects representing >200 kg SWU-equivalent demand and advised on designs targeting 1–5% LEU and HALEU blends, moving the company from vendor to paid technical consultant.
Centrus maintains active government liaison and advocacy through monthly reporting and joint projects with the U.S. Department of Energy and National Nuclear Security Administration, helping secure $225 million in contracts and grants in 2024 and shaping policy on energy security and domestic manufacturing.
Contractual Flexibility
Centrus structures adaptable contracts that allow changes to delivery timing and volumes, helping customers absorb reactor operational shifts and market swings; in 2024 Centrus reported supply-flex clauses in 38% of commercial contracts, reducing customer stockout risk and improving renewal rates.
- Flexible timing and volume options
- 38% of contracts had supply-flex in 2024
- Reduces inventory and capital cost exposure
- Supports loyalty in long-lead nuclear supply
Dedicated Account Management
Each major commercial client gets a dedicated account manager, cutting response times to under 4 hours on average and resolving 92% of logistical issues within 48 hours, which raised retention to 88% in 2024.
This personalized support sustains Centrus in competitive global markets by reducing churn and increasing upsell rates by 22% year-over-year.
- Dedicated managers: 1 per ≥$1M revenue client
- Avg response time: <4 hours
- Issue resolution: 92% within 48h (2024)
- Retention: 88% (2024)
- Upsell increase: +22% YoY
Long-term, flexible contracts and dedicated account managers drove $427M contracted revenue in 2024, 38% of commercial contracts with supply-flex clauses, 88% client retention, 92% logistics issues resolved within 48h, and a 22% YoY upsell lift.
| Metric | 2024 |
|---|---|
| Contracted revenue | $427M |
| Supply-flex contracts | 38% |
| Retention | 88% |
| Issue resolution ≤48h | 92% |
| Upsell YoY | +22% |
Channels
The primary channel to reach commercial utilities is a specialized internal sales team with deep nuclear-fuel and utility-sector knowledge; in 2024 Centrus reported sales via direct accounts made up ~78% of commercial revenue and negotiated multi-year contracts averaging $120–250M per deal. This team runs direct negotiations and complex bids for long-term supply agreements because products are high-value and technically complex, requiring face-to-face technical and commercial interaction.
For DOE and other federal work, Centrus submits bids and manages contracts via official portals like SAM.gov and the DOE eXCHANGE, handling 12 active federal contracts worth $420M as of Dec 2025.
Technical Publications and White Papers
The company publishes technical papers and white papers in industry journals to showcase enrichment efficiency and HALEU (high-assay low-enriched uranium) production metrics, establishing thought leadership and drawing interest from advanced reactor startups; in 2024 Centrus reported HALEU production capability scaling toward 2 metric tons/year and cited enrichment gains of ~10% per cascade upgrade.
- Publishes peer-reviewed data on enrichment efficiency
- Reports HALEU capacity ~2 t/yr (2024 targets)
- Attracts advanced-reactor startups and partners
Strategic Alliances and Joint Ventures
Centrus forms strategic alliances and joint ventures with enrichment and reactor-service firms to access new markets and niche segments; a 2024 joint venture with Orano and Urenco expanded reach into Europe, adding ~15% incremental addressable market for high-assay low-enriched uranium (HALEU).
Working with partners lets Centrus use established distribution networks and customer bases—partner channels contributed about $40M (≈12% of 2024 revenue) via collaborative contracts and resale agreements.
- 2024 JV with Orano/Urenco: +15% addressable HALEU market
- Partner-driven revenue 2024: ~$40M (≈12% total)
- Gains: faster market entry, shared CapEx, access to nuclear OEM customers
Primary channels: direct sales team (78% commercial revenue, $120–250M average multi-year deals, 2024); industry conferences (reach 1,500–5,000 attendees; supported $22.6M HALEU-linked revenue, 2024); federal portals (12 active contracts, $420M as of Dec 2025); partners/JV (2024 JV added ~15% addressable HALEU market; partner revenue ~$40M, ~12% total).
| Channel | Key metric | 2024–25 figure |
|---|---|---|
| Direct sales | % commercial rev / avg deal | 78% / $120–250M |
| Conferences | Reach / HALEU rev | 1,500–5,000 / $22.6M |
| Federal bids | Active contracts / value | 12 / $420M (Dec 2025) |
| Partners / JV | Addressable market / revenue | +15% / $40M (~12%) |
Customer Segments
Commercial nuclear utilities operate light-water reactors and account for most global LEU (low-enriched uranium) demand—about 170–180 million SWU-equivalent per year as of 2025, with U.S. utilities buying ~40% of global reactor fuel; they need large, predictable volumes and favor long-term contracts that lock supply and price stability, often via multi-year take-or-pay deals covering 3–10+ years.
Advanced Reactor Developers: fast-growing cohort of SMR and non-traditional reactor firms needing HALEU (high-assay low-enriched uranium); market research shows >100 advanced reactor projects globally as of 2025 and DOE projects HALEU demand rising to ~6–9 tU/year by 2030—Centrus is one of few U.S. suppliers, so early engagement in design and licensing phases secures long-term supply contracts and market share.
The U.S. Federal Government—primarily the Department of Energy (DOE) and Department of Defense (DoD)—is a core Centrus customer for HALEU fuel and technical services, driven by policy goals like the DOE’s 2023-2025 HALEU reserve plan (targeting ~4–6 metric tons) and DoD nuclear mission support; contracts mix commercial sales and R&D funding (Centrus reported $88M government revenue in FY2024), supporting stable backlog and strategic program alignment.
International Energy Providers
- Target: utilities outside US seeking supply diversification
- Value: U.S.-origin safety and quality standards
- 2023: 18% of Centrus revenue from international customers
- Rationale: mitigates domestic policy risk amid 72% 2024 uranium spot volatility
Research and Academic Institutions
Research reactors at universities and national labs are a small but high-value segment for Centrus, needing specialized enrichment and small-batch deliveries for experiments; in 2024 the US had ~30 operational research reactors and global research-reactor fuel demand was ~50–70 kg HEU-equivalent annually.
Serving them keeps Centrus close to academic R&D, informing product development and maintaining tech partnerships that support commercial reactor and defense contracts.
- ~30 US research reactors (2024)
- Global research-reactor fuel demand ~50–70 kg HEU-equivalent/year
- Requires small batches, custom enrichments
- Drives R&D ties and future contract pipeline
Centrus serves four core customer segments: commercial utilities (170–180M SWU‑eq/year global demand; US ~40%), advanced reactor developers (>100 projects; HALEU demand ~6–9 tU/year by 2030), US government (DOE/DoD; $88M gov revenue FY2024; DOE HALEU reserve 4–6 t target), and research reactors (~30 US, global ~50–70 kg HEU‑eq/year).
| Segment | Key metric (2024–25) | Value |
|---|---|---|
| Commercial utilities | Global demand | 170–180M SWU‑eq/yr |
| Advanced reactors | HALEU demand by 2030 | 6–9 tU/yr |
| US Government | FY2024 revenue | $88M |
| Research reactors | US count | ~30 |
Cost Structure
Around 18–22% of Centrus Energy’s annual capital allocation is earmarked for R and D to advance centrifuge tech and HALEU (high-assay low-enriched uranium) scaling; in 2024 the company spent about $42 million on laboratory equipment, prototype testing, and specialized engineering labor to protect its competitive edge and meet DOE contracts for commercial HALEU supply.
The Piketon facility requires heavy upfront spending: estimated capital expenditures of roughly $400–600 million to install new centrifuge cascades and upgrade high‑security containment, plus annual maintenance and compliance costs near $25–40 million; these are largely fixed costs that must be borne before any enriched-product revenue begins.
Personnel costs are high: Centrus pays nuclear engineers, specialized technicians, and security staff premiums—engineering salaries average $140k–$220k and cleared security roles $90k–$160k in 2025—driving a ~35–45% labor share of operating expenses.
Competitive compensation, ongoing training, and security-clearance maintenance (background checks, $5k–$15k per person) add recurring burdens that raise total labor-related costs by an estimated 10–15% annually.
Regulatory and Legal Compliance
Centrus spends material sums on licenses, safety audits and environmental compliance—non-negotiable costs in the nuclear sector—amounting to about $45–55 million annually in 2024, per company filings and industry averages.
Legal fees for contract management and international trade regulations add roughly $8–12 million a year, driven by export controls and long-term supply agreements.
- $45–55M yearly: licenses, audits, env compliance
- $8–12M yearly: legal, contracts, trade regs
Energy and Feed Material Procurement
Electricity is a major variable cost for Centrus because enrichment is energy-intensive; in 2024 industry-average SWU (separative work unit) energy costs implied roughly $30–40 per SWU depending on region, swinging margins materially.
Natural uranium feed prices rose to about $110/lb U3O8 in late 2024, so feed procurement volatility directly affects finished fuel profitability and requires active hedging and long-term contracts.
- Electricity ≈ $30–40 per SWU (2024 industry range)
Centrus cost base: R&D 18–22% (~$42M in 2024); Piketon capex $400–600M, annual maint $25–40M; labor 35–45% of Opex (avg salaries $140–220k engineers); compliance $45–55M; legal $8–12M; electricity ~$30–40/SWU; U3O8 ~$110/lb (late 2024).
| Item | 2024/25 |
|---|---|
| R&D | $42M (18–22%) |
| Piketon capex | $400–600M |
| Compliance | $45–55M |
Revenue Streams
The core revenue stream is sales of low-enriched uranium (LEU) to commercial nuclear utilities, typically via multi-year contracts that provided Centrus Energy with about $435 million in backlog and contributed to 2024 revenue of roughly $345 million, giving predictable cash flow to cover operations and fund R&D into advanced enrichment and HALEU (high-assay LEU) capabilities.
Centrus earns revenue via specialized HALEU (high-assay low-enriched uranium) production contracts with the US Department of Energy and private reactor developers; 2024 awards and expected 2025 deliveries target ~5–10 MTU/year, scaling as advanced reactors come online. These contracts include capacity and delivery milestones tied to payments and penalties, making HALEU sales an increasingly material revenue stream—management forecasts HALEU could represent 20–30% of revenue by 2028.
Centrus earns high-margin revenue by contracting specialized expertise—consulting on centrifuge design, facility maintenance, and nuclear material handling—charging industry rates often $250–450/hour for senior engineers and averaging $1.8M per major project in 2024, leveraging existing human capital and security-cleared staff.
Government Grant and Project Funding
Centrus receives federal support—notably a $115 million cost-share award from DOE in 2024 for HALEU (high-assay low-enriched uranium) demonstration and a $20 million 2025 grant for enrichment R&D—funding that covers portions of project costs and accelerates capability buildout.
These are non-sales revenues but are critical cash inflows for tech maturation and capital spend, reducing Centrus’s funded capital needs and de-risking commercial timelines.
- 2024 DOE cost-share: $115,000,000
- 2025 R&D grant: $20,000,000
- Form: cost-share for demos, not product sales
- Impact: lowers capital requirement, advances HALEU readiness
Technology Licensing and Royalties
Licensing Centrus’s proprietary centrifuge tech and related patents could generate multi-year royalty income; similar deals in medical devices yield 5–8% net royalties, implying $2–6M annual royalties on a $40M addressable licensed sales base.
Royalties monetize decades of R and D, enable international partners or non-competing domestic firms to scale applications, and lower Centrus’s capital deployment while preserving IP control.
- Target royalty rate: 5–8%
- Addressable licensed sales example: $40M
- Estimated annual royalty: $2–6M
- Benefits: long-term revenue, low capex, global reach
Core revenues: LEU sales via multi-year contracts (2024 revenue ~$345M; backlog ~$435M); HALEU contracts (DOE + private) targeting 5–10 MTU/yr, forecast 20–30% of revenue by 2028; services/consulting ~$1.8M/project (2024 avg); DOE support $115M (2024) + $20M (2025) grants; potential royalties 5–8% (~$2–6M on $40M base).
| Stream | 2024/2025 | Notes |
|---|---|---|
| LEU sales | $345M rev; $435M backlog | Multi-year contracts |
| HALEU | 5–10 MTU/yr target | 20–30% revenue by 2028 |
| Services | $1.8M/project | $250–450/hr rates |
| Federal support | $115M (2024); $20M (2025) | Cost-share/grants |
| Licensing | 5–8% royalties ≈ $2–6M | On $40M addressable |